Research projects

RHEUMAI Research

We have STORM and STORM APS, two opportunities for working with patients and set the new era of pharmacology and directed therapies. Also we created agents for CRA completion and clinical companion& x20;

From target binding to neuropharmacological effects: what should count as a credible computational forecast?

One of the central problems in computational neuropharmacology is deciding what we actually mean when we say that a model can “predict” or “forecast” the effects of a compound on the brain. Target binding data are an obvious starting point…

HelixMind

HelixMind is an interconnected system of biological labs that runs simulations, predictions, and experiments on human DNA, bacteria, viruses, fungi, and more — under any environment or condition — before anything touches a real lab bench.…

Signal Secretome

Developing a stem cell secretome nasal spray for neuroinflammation, with an initial focus on whether whole secretome can outperform purified exosomes and be engineered into a stable, scalable intranasal product.

Discover a STAT6 binder to overcome inflammatory disease

Om Therapeutics is developing a STAT6 research program combining LULA predictions with experimental testing of small molecules. Our first objective is to define and run a focused screening campaign, evaluate reproducibility, and determine…

Material research

Operating out of Melbourne Australia, we are developing bio material and bio composites for healthier humans and world.& x20;

Synthetic TME for Cancer Therapeutics Discovery

A collaborative initiative to develop and apply synthetic tumour microenvironment models that improve cancer therapeutic discovery, translational relevance, and response prediction.

SpaceBio AI-powered Drug Discovery Platform

Humanity’s expansion into the Solar System is inevitable yet poses major challenges to astronaut health, requiring bio innovation in resilience to radiation, microgravity, and more. Our pharmacogenomic AI agentic platform leverages populat…

Chemical Evolution of Thai Moonseed Family

This project investigates the diversity and evolutionary history of specialized chemical compounds in Thai members of the moonseed family (Menispermaceae). By integrating phytochemical profiles with phylogenetic data, it aims to reveal how…

Ejochi Vitality: Standardized Botanical Validation Pipeline

Can we produce reproducible, QC‑released batches of A 5:‌1 blend of Sphenoce‌ntrum jollyanum (acute neurovas⁠c‍ular trigge‌r) a‍n⁠‍d Eur⁠y‍coma l⁠o‌⁠ngifoli& x61; & x2060; (c⁠hronic endo‍crin⁠e/str⁠e‌ss‌ modul⁠at⁠or) f‍or male vit‌ality me…

Track 2 — Pill: Immunometabolism Regulators

mTOR inhibition extends lifespan; the NLRP3 inflammasome drives autoimmune, metabolic, and neurodegenerative aging diseases. AI identifies safe immunometabolism regulators from clinically tested compounds and natural products. Route: Oral…

Track 1 — Peptide Gel: Microcirculation Rejuvenation

Microvascular aging precedes organ aging, reducing blood flow and impairing vasodilation. AI designed peptides mimic VEGF A signaling to delay or reverse microvascular aging, optimized computationally for stability and skin penetration. Ro…